10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The integration of genomics and bioinformatics has become a cornerstone in the fight against infectious diseases, providing a deeper understanding of pathogen biology and disease progression. Through the use of genomic sequencing and bioinformatic analysis, scientists can investigate the genetic variability of infectious agents, monitor resistance patterns, and develop more precise diagnostic tools. Genomics and bioinformatics in infectious diseases facilitate the identification of novel biomarkers, which are essential for the early detection and treatment of infections. Moreover, these technologies enable real-time surveillance of pathogen evolution, allowing healthcare systems to respond quickly to emerging infectious threats with tailored interventions. The ongoing refinement of these tools holds the potential to drastically improve global health outcomes.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria